1. Volume 132, Issue 3, Pages 931-937 (March 2007)
Lamivudine Plus Low-Dose Hepatitis B Immunoglobulin to Prevent Recurrent Hepatitis B Following Liver Transplantation 
Edward J. Gane, Peter W. Angus, Simone Strasser, Darrell H.G. Crawford, John Ring, Gary P. Jeffrey, Geoffrey W. McCaughan 
Gastroenterology 
Volume 132, Issue 3, Pages (March 2007)
DOI: /j.gastro
Copyright © 2007 AGA Institute Terms and Conditions

2. Figure 1
Posttransplantation survival according to the pretransplantation diagnosis of hepatocellular carcinoma. (A) Sixty-two patients listed with hepatocellular carcinoma. (B) Eighty-five patients listed for liver failure without hepatocellular carcinoma (P = .01; log-rank test).
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2007 AGA Institute Terms and Conditions

3. Figure 2
Cumulative proportion of patients with recurrent hepatitis B following liver transplantation for hepatitis B (censored for death).
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2007 AGA Institute Terms and Conditions

4. Figure 3
Plasma (anti-HBs) titers at 1, 3, and 12 months posttransplantation (horizontal bars demonstrate median values).
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2007 AGA Institute Terms and Conditions